Description
BLOOD BANK GEL REAGENTS
First action · last action
2026-06-11 · 2026-06-11
Transactions
1
First transaction's obligation
$21,363
Base + all options value (sum of deltas)
$21,363
Extent competed
NOT COMPETED UNDER SAP
Other than full & open authority
AUTHORIZED BY STATUTE (FAR 6.302-5(A)(2)(I))
Set-aside
NO SET ASIDE USED.
Offers received
1
SDVOSB flag on record
No
Parent IDV
36C25526A0030
NAICS
325412 · PHARMACEUTICAL PREPARATION MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2026-06-11+$21,363= $21,363
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2026-06-11 | +$21,363 | $21,363 | BLOOD BANK GEL REAGENTS |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI ZFXRG96JMJ39)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24426N0813 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $126,199 | FY2026 |
| 36C24426N0812 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $106,952 | FY2026 |
| 36C24426N0811 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $9,494 | FY2026 |
| 36C24426A0042 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C25026N0609 | 250-NETWORK CONTRACT OFFICE 10 (36C250) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $16,220 | FY2026 |
| 36C25526A0030 | 255-NETWORK CONTRACT OFFICE 15 (36C255) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $0 | FY2026 |
Other recipients under 6550 from 255-NETWORK CONTRACT OFFICE 15 (36C255) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25526N0405 | FISHER SCIENTIFIC COMPANY L.L.C. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $113,611 | FY2026 |
| 36C25526N0337 | CEPHEID | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $2,571,141 | FY2026 |
| 36C25526N0307 | WERFEN USA LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $76,810 | FY2026 |
| 36C25526N0301 | BRANCH MEDICAL LLC | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $16,740 | FY2026 |
| 36C25526N0306 | ALBA BIOSCIENCE, INC. | 255-NETWORK CONTRACT OFFICE 15 (36C255) | $40,949 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25526N0312_3600_36C25526A0030_3600 · retrieved 2026-09-26.